Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1395-1406
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1395
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1395
Figure 5 Virological response of chronic hepatitis B patients with different grades of nonalcoholic fatty liver disease at different antiviral treatment duration.
Dynamic change trend of hepatitis B virus viral load. NAFLD: Nonalcoholic fatty liver disease; CHB: Chronic hepatitis B; HBV DNA: Hepatitis B virus deoxyribonucleic acid.
- Citation: Li HD, Liu YN, Wu S, Quan XF, Wang XY, Xiang TD, Li SM, Xu L, Wang T, Wang H, Zheng X. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus. World J Hepatol 2024; 16(12): 1395-1406
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1395.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1395